MG1111

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MG1111, covering 2017-04-27 to 2021-05-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MG1111 in Healthy Children [Phase 2, Phase 3]